Estimating the burden of disease from unsafe injections in India: A cost-benefit assessment of the auto-disable syringe in a country with low blood-borne virus prevalence

Estimating the burden of disease from unsafe injections in India: A cost-benefit assessment of the auto-disable syringe in a country with low blood-borne virus prevalence

Background: Unsafe medical injections are a prevalent risk factor for viral hepatitis and HIV in India. Objectives: This review undertakes a cost-benefit assessment of the auto-disable syringe, now being introduced to prevent the spread of hepatitis B virus, hepatitis C virus, and human immunodefici...

Full description

Bibliographic Details
Main Author:	Savanna Reid
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2012-01-01
Series:	Indian Journal of Community Medicine
Subjects:	Cost-benefit hepatitis B virus hepatitis C virus HIV injections
Online Access:	http://www.ijcm.org.in/article.asp?issn=0970-0218;year=2012;volume=37;issue=2;spage=89;epage=94;aulast=Reid

Similar Items

Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan
by: Meng-Hsuan Hsieh, et al.
Published: (2016-10-01)

Hepatitis E Virus among Persons Who Inject Drugs, San Diego, California, USA, 2009–2010
by: Reena Mahajan, et al.
Published: (2013-10-01)

Ongoing susceptibility to hepatitis B virus infection among people who inject drugs in Sydney
by: Bethany White, et al.
Published: (2012-08-01)

Drug Trafficking Routes and Hepatitis B in Injection Drug Users, Manipur, India
by: Sibnarayan Datta, et al.
Published: (2006-12-01)

Options for reducing HIV transmission related to the dead space in needles and syringes
by: William A. Zule, et al.
Published: (2018-01-01)

Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan
by: Meng-Hsuan Hsieh, et al.
Published: (2016-02-01)

HGV-HCV/HBV co-infection in India: A pilot study
by: Amruta D Pathare, et al.
Published: (2013-01-01)

Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern India
by: Debasish Basu, et al.
Published: (2015-01-01)

Hepatitis E virus: A leading cause of waterborne viral hepatitis in Northwest Districts of Punjab, India
by: Maninder Kaur, et al.
Published: (2017-04-01)

Hepatitis C in hemodialysis: the contribution of injection drug use
by: Bruno Galperim, et al.

Patients' Fear of Contracting the Blood-Borne Infections from Dentists
by: Fatemah Ayatollahi, et al.
Published: (2007-01-01)

Burden of Liver Cirrhosis in Portugal between 2010 and 2017
by: João Manuel Silva, et al.
Published: (2020-10-01)

Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals
by: Zachary C. Rich, et al.
Published: (2016-09-01)

Establishment of drug-resistant HBV small-animal models by hydrodynamic injection
by: Junjun Cheng, et al.
Published: (2014-08-01)

The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden
by: Lei Zhang, et al.
Published: (2019-11-01)

Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)
by: Lubov I. Petrova, et al.
Published: (2018-09-01)

Hepatitis G virus (HGV) infection in Saudi dialysis patients and healthy controls
by: Mitwalli Ahmed, et al.
Published: (2000-01-01)

Assessing the Global Burden of Hepatitis E Virus Associated with Genotypes 1, 2, 3 and 4
by: Saboui, Myriam
Published: (2016)

An analysis of association of human leukocyte antigen and liver disease patients in a tertiary care hospital, India
by: Simmi Mehra, et al.
Published: (2021-01-01)

Viral Genotypes and Associated Risk Factors of Hepatocellular Carcinoma in India
by: Manash Pratim Sarma, et al.
Published: (2012-09-01)

Epidemiología de las hepatitis virales en México Epidemiology of viral hepatitis in Mexico
by: Arturo Panduro, et al.
Published: (2011-01-01)

Hepatitis E: Genotypes, strategies to prevent and manage, and the existing knowledge gaps
by: Lubna Kamani, et al.
Published: (2021-10-01)

Early detection of unhealthy behaviors, the prevalence and receipt of antiviral treatment for disabled adult hepatitis B and C carriers
by: Sui-Whi Jane, et al.
Published: (2016-02-01)

The prevalence of human immunodeficiency virus type 1 and hepatitis C virus among injection drug users who use high risk inner-city locales in Miami, Florida
by: Clyde B McCoy, et al.
Published: (2004-12-01)

The Seroprevalence of Hepatitis B, C and E Viruses Among the Dustmen in Izmir
by: Ali Ilgın OLUT, et al.
Published: (2004-12-01)

Prevalence of hepatitis A, B and C serological markers in children from western Mexico(◆)(◆)This work was partially funded by a grant to AP from the Consejo Estatal de Ciencia y Tecnologia de Jalisco, México (COECYTJAL-UdeG).
by: Griselda Escobedo-Meléndez, et al.
Published: (2012-03-01)

Etymologia: Pegivirus
by: Ronnie Henry
Published: (2020-02-01)

Hepatitis E: Current Status in India and Other Asian Countries
by: Harsh Kumar, et al.
Published: (2019-03-01)

Hepatitis E and Pregnancy: An Unholy Alliance Unmasked from Kashmir, India
by: Mohammad Sultan Khuroo
Published: (2021-07-01)

Hepatitis E Virus Genotype 4 in Yak, Northwestern China
by: Fang Xu, et al.
Published: (2014-12-01)

Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers
by: Abbasali Javadi, et al.
Published: (2014-01-01)

HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar
by: Ahmed Khatib, et al.
Published: (2017-11-01)

Relative Frequency of Blood-Borne Viruses in Hemodialysis-Dependent and Kidney Transplant Recipients in Iran
by: Fatemeh HATATIAN, et al.
Published: (2020-10-01)

PreC and C Regions of Woodchuck Hepatitis Virus Facilitate Persistent Expression of Surface Antigen of Chimeric WHV-HBV Virus in the Hydrodynamic Injection BALB/c Mouse Model
by: Weimin Wu, et al.
Published: (2017-02-01)

Hepatitis B and C infections in HIV-1 patients on combination antiretroviral therapy (cART) in Ghana: implications for immunologic recovery, clinical response to treatment, and hepatotoxicity
by: Theophilus Benjamin Kwofie, et al.
Published: (2021-06-01)

Performance study of the automated immunoassay test anti-hepatitis C virus VIDAS® for the qualitative detection of antibodies anti-hepatitis C virus
by: Sara Salvetti, et al.
Published: (2016-03-01)

A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa
by: Marie Atsama Amougou, et al.
Published: (2016-11-01)

Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease?
by: Giovanni Raimondo, et al.
Published: (2005-04-01)

The unfolded protein response (UPR) in cultured cells expressing either wild-type or mutant hepatitis B e antigen (HBeAG) of the hepaptitis B virus(HBV)
by: Bhoola, Nimisha Harshadrai
Published: (2014)

Hepatitis C Virus Transmission Clusters in Public Health and Correctional Settings, Wisconsin, USA, 2016–2017
by: Karli R. Hochstatter, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_t8200dqg0hs5khtb75aigh3rau